FDA Adverse Event Malfunction Summary report: N

CR PLUS TIB BEARING, VIT E, SZ 7, 8MM

MDR report key: 20953579 · Received December 17, 2024

Report

Report Number
1220246-2024-08914
Event Type
Malfunction
Date Received
December 17, 2024
Date of Event
November 21, 2024
Report Date
July 10, 2025
Manufacturer
ARTHREX, INC.
Product Code
MBH
PMA / PMN Number
K171365
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
501

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: G3, H3, H6. BASED ON THE INFORMATION PROVIDED WHICH MAY INCLUDE THE DEVICE (IF AVAILABLE AND RETURNED), PICTURES, VIDEOS, EVENT DESCRIPTION, AND ANY ADDITIONAL INFORMATION FROM THE FIELD, ARTHREX WAS ABLE TO CONCLUDE A MOST LIKELY CAUSE. THE MOST LIKELY CAUSE FOR THE REPORTED FAILURE CAN BE ATTRIBUTED TO USER ERROR DUE TO MISALIGNED INSERTION AND/OR IMPROPER BONE PREPARATION.

Additional Manufacturer Narrative · 0

INVESTIGATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE PROVIDED UPON AVAILABILITY OF ADDITIONAL INFORMATION.

Description of Event or Problem · 0

ON (B)(6) 2024, IT WAS REPORTED BY A SALES REPRESENTATIVE VIA PHONE THAT AN AR-523-A708 CR PLUS TIBIAL BEARING HAD AN ISSUE DURING A TOTAL KNEE ARTHROPLASTY ON (B)(6)2024. WHEN THE SURGEON IMPLANTED IT IN THE TIBIAL TRAY, THE DEVICE WOULD NOT SEAT PROPERLY. THE SURGEON REMOVED THE AR-523-A708 CR PLUS TIBIAL BEARING IN ONE PIECE; NOTHING BROKE INSIDE THE PATIENT, AND THERE WAS NO PATIENT HARM. ANOTHER R-523-A708 CR PLUS TIBIAL BEARING WITH LOT NUMBER 579202786 WAS USED TO COMPLETE THE PROCEDURE SUCCESSFULLY. THE DEVICE WAS DISCARDED, AND NO PICTURES WERE TAKEN. THERE WAS NO CASE DELAY REPORTED AND NO ADDITIONAL ANESTHESIA WAS ADMINISTERED. THIS OCCURRED DURING USE WITH NO REPORTED PATIENT HARM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
267364 CR PLUS TIB BEARING, VIT E, SZ 7, 8MM KNEE PROSTHESIS PAT/FEM/TIB MBH ARTHREX, INC. CR PLUS TIB BEARING, VIT E, SZ 7, 8MM 579202663

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown